1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Global Health Program for Fellows and Scholars (LAUNCH) is sponsored by NIH Fogarty International Center. This program offers a year of mentored research training in global health at established biomedical and health research institutions and project sites in Low- and Middle-Income Countries (LMICs) for postdoctoral trainees and doctoral students from the U.S. and LMICs.
Get alerted about grants like this
Save a search for “NIH Fogarty International Center” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Predoctoral and postdoctoral U.S. trainees; eligibility varies by consortium. Doctoral students in health professions and postdoctoral trainees from the US and partner countries are eligible. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Mobile Health (mHealth) is a grant from the NIH Fogarty International Center that funds exploratory and developmental research on innovative mobile health interventions and tools designed for low- and middle-income countries (LMICs). The R21/R33 program supports up to two years of technology development and feasibility studies (R21 phase), with possible transition to larger validation and effectiveness studies (R33 phase). Eligible projects must use new or emerging mobile and wireless technology; SMS-only interventions are not eligible. US institutions must involve LMIC researchers as key personnel. LMIC institutions may apply independently or with US partners. This grant is issued by Fogarty in collaboration with multiple NIH institutes including NCI, NIMH, NIBIB, and NICHD. Award amounts vary based on phase and scope.
LAUNCHing Leaders for Future U.S. Investments in Global Health Research is a grant from NIH Fogarty International Center (RFA-TW-25-002) that funds international research training programs to build global health research capacity in low- and middle-income countries. The D43 training grant mechanism supports structured programs at universities that develop the next generation of global health researchers and strengthen partnerships with U.S. institutions. The program advances U.S. investments in global health by building a pipeline of highly trained international investigators. Eligible applicants are universities in low- and middle-income countries partnering with U.S. institutions. The estimated application deadline is May 25, 2026.
Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program (PA-26-085) is sponsored by NIH Fogarty International Center. This program funds collaborative health research projects between U.S. and Finnish universities. While not explicitly focused on traditional medicine or complementary health, research in global health could be part of the collaborative projects.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.